BlackRock Fund Advisors - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 14 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2016$867,000
+28.4%
102,550
+3.1%
0.00%
Q3 2016$675,000
+168.9%
99,448
+18.4%
0.00%
Q2 2016$251,000
+169.9%
83,962
+63.5%
0.00%
Q1 2016$93,000
+3.3%
51,368
-6.2%
0.00%
Q4 2015$90,000
+12.5%
54,790
+7.4%
0.00%
Q3 2015$80,000
-50.3%
51,004
-2.6%
0.00%
Q2 2015$161,00052,3540.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2015
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders